Literature DB >> 17316993

Fos-like immunoreactivity in rat dorsal raphe nuclei induced by alkaloid extract of Mitragyna speciosa.

Ekkasit Kumarnsit1, Uraporn Vongvatcharanon, Niwat Keawpradub, Pranom Intasaro.   

Abstract

Mitragyna speciosa (MS) has been traditionally used for medicinal purposes especially in southern Thailand. Previously, an alkaloid extract of this plant was demonstrated to mediate antinociception, partly, through the descending serotonergic system. The present study investigated the stimulatory effect of the MS extract on the dorsal raphe nucleus and its antidepressant-like activity. The MS extract containing approximately 60% mitragynine as a major indole alkaloid was used to treat the animals. The stimulatory effect of the MS extract was determined by detecting the expression of the immediate early gene, cfos, in the dorsal raphe nucleus of male Wistar rats. The immunohistochemistry was used to detect Fos protein, the protein product of cfos gene. The present data show that a significant increase in Fos expression was observed following long-term administration of the MS extract (40 mg/kg) for 60 consecutive days. In addition, the antidepressant-like activity of the MS extract was determined by using the forced swimming test (FST) in male mice. The results show that a single injection (either 60 or 90 mg/kg doses) significantly decreased immobility time in the FST. These findings indicate that the MS extract has a stimulatory effect on the dorsal raphe nucleus and an antidepressant-like activity. Stimulation of this brain area has been known to cause antinociception. These findings suggest that the MS extract might produce antinociceptive and/or antidepressive actions partly through activation of the dorsal raphe nucleus. Moreover, the dorsal raphe nucleus may be one of site of MS action in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316993     DOI: 10.1016/j.neulet.2007.01.061

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Indole Alkaloids from Plants as Potential Leads for Antidepressant Drugs: A Mini Review.

Authors:  Hazrulrizawati A Hamid; Aizi N M Ramli; Mashitah M Yusoff
Journal:  Front Pharmacol       Date:  2017-02-28       Impact factor: 5.810

Review 2.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157

Review 3.  The Potential for Kratom as an Antidepressant and Antipsychotic.

Authors:  Lindsay E Johnson; Lilian Balyan; Amy Magdalany; Fizza Saeed; Robert Salinas; Starla Wallace; Charles A Veltri; Marc T Swogger; Zach Walsh; Oliver Grundmann
Journal:  Yale J Biol Med       Date:  2020-06-29

4.  Antinociceptive action of isolated mitragynine from Mitragyna Speciosa through activation of opioid receptor system.

Authors:  Abdul Rahman Shamima; Sharida Fakurazi; Mohamad Taufik Hidayat; Ithnin Hairuszah; Mohamad Aris Mohd Moklas; Palanisamy Arulselvan
Journal:  Int J Mol Sci       Date:  2012-09-12       Impact factor: 6.208

Review 5.  A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans.

Authors:  Elisabeth Prevete; Kim Paula Colette Kuypers; Eef Lien Theunissen; Ornella Corazza; Giuseppe Bersani; Johannes Gerardus Ramaekers
Journal:  Hum Psychopharmacol       Date:  2021-07-26       Impact factor: 2.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.